Arie Regev

6.5k total citations · 1 hit paper
95 papers, 4.7k citations indexed

About

Arie Regev is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Arie Regev has authored 95 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 42 papers in Epidemiology and 20 papers in Pharmacology. Recurrent topics in Arie Regev's work include Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (29 papers) and Drug-Induced Hepatotoxicity and Protection (19 papers). Arie Regev is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (29 papers) and Drug-Induced Hepatotoxicity and Protection (19 papers). Arie Regev collaborates with scholars based in United States, Israel and United Kingdom. Arie Regev's co-authors include Eugene R. Schiff, Lennox J. Jeffers, Enrique Molina, K. Rajender Reddy, Mariana Berho, Nikolaos Pyrsopoulos, Clara Milikowski, Ayse L. Mindikoglu, Andreas G. Tzakis and Meir Lahav and has published in prestigious journals such as Gastroenterology, Hepatology and Neurology.

In The Last Decade

Arie Regev

93 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

2002 1.7k citations Arie Regev, Lennox J. Jeffers et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arie Regev United States	34	2.8k	2.6k	936	380	355	95	4.7k
Georges‐Philippe Pageaux France	40	2.4k 0.9×	2.9k 1.1×	1.3k 1.4×	318 0.8×	771 2.2×	178	4.6k
Guy Neff United States	35	3.0k 1.1×	2.7k 1.0×	1.6k 1.7×	165 0.4×	510 1.4×	141	4.9k
Jeffrey S. Crippin United States	31	2.6k 1.0×	3.3k 1.3×	1.3k 1.4×	1.4k 3.6×	252 0.7×	81	5.2k
Paul Gow Australia	31	1.9k 0.7×	2.2k 0.8×	945 1.0×	284 0.7×	153 0.4×	173	3.9k
P. Michielsen Belgium	34	2.1k 0.8×	1.5k 0.6×	662 0.7×	211 0.6×	130 0.4×	219	4.0k
Sumita Verma United Kingdom	28	2.0k 0.7×	1.9k 0.8×	1.2k 1.3×	473 1.2×	163 0.5×	89	3.4k
Christophe Moreno Belgium	44	4.3k 1.6×	3.3k 1.3×	862 0.9×	220 0.6×	96 0.3×	171	6.0k
Sanjaya K. Satapathy United States	31	2.5k 0.9×	1.7k 0.7×	825 0.9×	164 0.4×	110 0.3×	170	3.7k
Massimo Rossi Italy	36	1.6k 0.6×	2.6k 1.0×	2.1k 2.3×	130 0.3×	334 0.9×	280	4.8k
Sébastien Dharancy France	37	4.6k 1.6×	3.4k 1.3×	1.9k 2.0×	209 0.6×	387 1.1×	159	6.7k

Countries citing papers authored by Arie Regev

Since Specialization

Citations

This map shows the geographic impact of Arie Regev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Regev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Regev more than expected).

Fields of papers citing papers by Arie Regev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arie Regev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Regev. The network helps show where Arie Regev may publish in the future.

Co-authorship network of co-authors of Arie Regev

This figure shows the co-authorship network connecting the top 25 collaborators of Arie Regev. A scholar is included among the top collaborators of Arie Regev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie Regev. Arie Regev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chalasani, Naga, Paul H. Hayashi, Debra Luffer‐Atlas, Arie Regev, & Paul B. Watkins. (2025). Assessment of liver injury potential of investigational medicines in drug development. Hepatology. 2 indexed citations

Wickremsinhe, Enaksha, Erwin Berthier, Diego López de Castilla, et al.. (2022). Standard Venipuncture vs a Capillary Blood Collection Device for the Prospective Determination of Abnormal Liver Chemistry. The Journal of Applied Laboratory Medicine. 8(3). 535–550. 35 indexed citations

Fontana, Robert J., Mark Avigan, Harry L.A. Janssen, et al.. (2019). Liver safety assessment in clinical trials of new agents for chronic hepatitis B. Journal of Viral Hepatitis. 27(2). 96–109. 11 indexed citations

Regev, Arie, et al.. (2019). Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Drug Safety. 42(6). 701–711. 19 indexed citations

Regev, Arie, Angelo Camporeale, Vladimir Skljarevski, Shufang Wang, & Jeff Carter. (2017). Hepatic safety of galcanezumab in patients with migraine: Results of three Phase 2 double-blind placebo-controlled trials (P2.164). Neurology. 88(16_supplement). 2 indexed citations

Jin, Yan, Arie Regev, Krista M Phipps, et al.. (2017). Dose‐dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor. British Journal of Clinical Pharmacology. 84(1). 179–188. 21 indexed citations

Mindikoglu, Ayse L., Arie Regev, Stephen L. Seliger, & Laurence S. Magder. (2010). Gender disparity in liver transplant waiting-list mortality: The importance of kidney function. Liver Transplantation. 16(10). 1147–1157. 67 indexed citations

Mindikoglu, Ayse L., et al.. (2009). Outcomes of Liver Transplantation in Patients with Cirrhosis due to Nonalcoholic Steatohepatitis Versus Patients with Cirrhosis due to Alcoholic Liver Disease. Liver Transplantation. 15(12). 1814–1820. 142 indexed citations

Mindikoglu, Ayse L., Laurence S. Magder, & Arie Regev. (2009). Outcome of Liver Transplantation for Drug-Induced Acute Liver Failure in the United States: Analysis of the United Network for Organ Sharing Database. Liver Transplantation. 15(7). 719–729. 73 indexed citations

10.

Bangs, Mark E., Ling Jin, Shuyu Zhang, et al.. (2008). Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder. Drug Safety. 31(4). 345–354. 48 indexed citations

11.

Weppler, Debbie, et al.. (2008). Effect of Pretransplant Hepatitis C Virus RNA Status on Posttransplant Outcome. Transplantation Proceedings. 40(5). 1449–1455. 10 indexed citations

12.

Yoshida, Hideo, Tomoaki Kato, David Levi, et al.. (2007). Lamivudine monoprophylaxis for liver transplant recipients with non‐replicating hepatitis B virus infection. Clinical Transplantation. 21(2). 166–171. 33 indexed citations

13.

Regev, Arie. (2007). Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy.. PubMed. 3(4). 265–6.

14.

Díaz, Francisco J., Sofía García, Arie Regev, et al.. (2007). Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut. 57(2). 232–242. 37 indexed citations

15.

Schreibman, Ian & Arie Regev. (2006). Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management.. PubMed. 8(2). 30–30. 9 indexed citations

16.

Molina, Enrique, et al.. (2005). Liver enzymes elevation after HAART in HIV‐HCV co‐infection. Journal of Viral Hepatitis. 12(4). 429–434. 15 indexed citations

17.

Mindikoglu, Ayse L., Arie Regev, Joé U. Levi, Javier Casillas, & Eugene R. Schiff. (2005). Focal Nodular Hyperplasia in Identical Twins. The American Journal of Gastroenterology. 100(7). 1616–1619. 8 indexed citations

18.

Tzakis, Andreas G., Tomoaki Kato, Seigo Nishida, et al.. (2003). Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation. 75(8). 1227–1231. 68 indexed citations

19.

Regev, Arie, Pinhas Stark, Dorit Blickstein, & Meir Lahav. (1997). Thrombotic complications in essential thrombocythemia with relatively low platelet counts. American Journal of Hematology. 56(3). 168–172. 85 indexed citations

20.

Leibovici, L., et al.. (1996). Influence of Diabetes Mellitus and Glycaemic Control on the Characteristics and Outcome of Common Infections. Diabetic Medicine. 13(5). 457–463. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact